Evotec SE announced that Dr. Craig Johnstone, the company’s Chief Operating Officer, will step down on 31 December 2024. Dr. Johnstone joined E ...

(IN BRIEF) Evotec SE announced that Dr. Craig Johnstone, the company’s Chief Operating Officer, will step down on 31 December 2024. Dr. Johnstone joined Evotec in 2012 and held various leadership ...

Evotec said Friday that its Chief Operating Officer Craig Johnstone will step down and leave the company in December. The German drug developer said Johnstone's responsibilities will be distributed ...

Evotec (EVO) announced that its Chief Operating Officer, Dr Craig Johnstone, will step down and leave the company effective December 31. Dr Johnstone joined Evotec in May 2012 as SVP Drug Discovery ...

HAMBURG, GERMANY / ACCESSWIRE / November 29, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Chief Operating Officer, Dr Craig ...

The company's recent appearance at the Frankfurt Equity Forum left many strategic questions unanswered, highlighting the significant challenges Evotec faces in its future strategic positioning. Fresh ...

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today ...

Halozyme made the €11-per-share offer earlier this month, valuing Evotec at around €2 billion ($2.1 billion), saying at the ...

As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech ...

Fresh Evotec information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Germany’s Evotec says it has taken notice of the statement made by Halozyme Therapeutics on November 22, stating that it has withdrawn its non-binding proposal to acquire Evotec for 11.00 euros per ...

Halozyme Therapeutics, a San Diego-based biopharmaceutical company, has made a $2.1 billion bid to buy German drugmaker ...